Investigating the genomic alteration improved the clinical outcome of aged patients with lung carcinoma

Investigating the genomic alteration improved the clinical outcome of aged patients with lung carcinoma

Abstract Background Lung carcinoma is a common geriatric disease. The development of genotype-targeted therapies greatly improved the management of lung carcinoma. However, the treatment for old patients can be more complex than that for young individuals. Results To investigate the benefits of gene...

Full description

Bibliographic Details
Main Authors: Sixian Chen, Aizhen Fu, Yuan Lu, Wei Lu, Yongfeng Chen, Shuiqiang Hong, Suli Zhou, Tianmin Xiang, Zhenzhen Zhang, Yongguang Cai
Format: Article
Language:English
Published: BMC 2022-01-01
Series:BMC Genomics
Subjects:
Lung cancer
Genomic alterations
KRAS codon 61
Targeted treatment
Mechanism of resistance
Online Access:https://doi.org/10.1186/s12864-021-08289-4

Internet

https://doi.org/10.1186/s12864-021-08289-4

Similar Items